$SES

Pilkington Kyle sold $30K of SES

Pilkington Kyle (CHIEF LEGAL OFFICER) sold 25,000 shares of SES AI Corp (SES) at $1.20 on 2026-05-22 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Pilkington Kyle
Published May 27, 2026, 9:30 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI May 27, 2026, 9:30 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$SES
Neutral
medium confidence
Mentioned
$SES
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$SESNeutralLow
01

Why it matters

The disclosure may slightly influence short-term sentiment, but it does not provide new information about earnings, contracts, litigation, or product milestones.

02

Market read

Traders may monitor insider activity, but this specific filing is unlikely to drive sustained repricing without additional company-specific catalysts.

03

What to watch

Check for clustering of insider transactions (buys vs sells) and whether there are concurrent material disclosures; a lone sale often has limited predictive value.

Relevance 6/10Timing: Immediate (filed 2026-05-27; sale dated 2026-05-22) but typically low signal for price discovery.

Background

The article is an SEC EDGAR Form 4 insider transaction disclosure for SES AI Corp, filed by a chief legal officer.

Company-level read

Ticker impact

$SESNeutralMedium confidence
Context

SEC Form 4 shows SES officer Kyle Pilkington sold 25,000 shares in an open-market transaction for ~$30.0K.

Expected impact

Likely limited near-term impact; any reaction should fade unless follow-on filings or operational news emerge.

Evidence & confidence

The filing is a routine Form 4 with a stated 10b5-1 plan, which typically reduces the signal of new negative information.

Market effects

Minimal—single insider sale without accompanying operational/regulatory updates is unlikely to reset sector expectations.

Minimal.

Minimal.

Counterpoint

Because the sale is explicitly under a pre-arranged 10b5-1 plan, it may reflect liquidity/compensation mechanics rather than bearish expectations.

Key entities

  • SES AI Corp

    Public company whose officer insider sale is disclosed on SEC Form 4.

  • Kyle Pilkington

    Chief Legal Officer who sold 25,000 shares under an open-market transaction with a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$SESHighAI 9/10

Europe confirms orders for IRIS2

The European Commission and ESA ordered the €15.6B IRIS2 satellite project. Aerospacelab won a €2.4B contract for 264 satellites, beating Airbus. Airbus secured a €500M order for 66 military satellites. Thales Alenia Space will supply payloads. SES ordered 18 MEO satellites from OHB SE for €1B. Eutelsat plans to order 229 more OneWeb satellites from Airbus for €1B.

$SESMed

SpaceX Successfully Launches Final Three Satellites for SES’s O3b mPower Constellation

SpaceX launched the final three satellites for SES's O3b mPower constellation, completing a decade-long project. The satellites will operate in medium Earth orbit, targeting enterprise-grade connectivity. This mission was SpaceX's 29th flight to orbit, with the Falcon 9 rocket successfully landing on a droneship. The O3b mPower constellation, consisting of 13 satellites, complements SpaceX's Starlink network, offering specialized services for commercial and government clients.

$SESMedAI 8/10

SES AI (SES) Q2 2026 Earnings Call Transcript

SES AI reported Q2 2026 revenue of $5.1M, up 40% YoY, with GAAP gross margin at 22.6%. Full-year revenue guidance remains $30M-$35M. The company has $163M in cash and expects drone cell production to reach 1M units annually by Q4 2026. ESS contributed over 70% of revenue, while GAAP net loss was $17.8M.

$SESMed

SES AI Received Notice of Delisting

According to an SEC filing by SES AI Corp, the NYSE notified the company on Aug. 13, 2026 that it will begin delisting proceedings and immediately suspended trading of SES AI’s public warrants due to an abnormally low selling price under NYSE rules. The NYSE plans to apply to the SEC to delist the warrants. Trading of Class A common stock (NYSE: SES) is unaffected.